Its carcinogenic role is attributed to its oncoproteins E6 and E7 that, respectively, degrade two tumor-suppressor proteins, namely, the guardian of the genome, also known as tumor protein p53, and the retinoblastoma protein (pRb), and thus promote aberrant cell proliferation and the initial steps of carcinogenesis [21]. This evidence concerns the gene TP53 and neoplasm.